Loading
Life sciences · Journal article
Chemistryselect · August 1, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an exploratory in vitro chemical and functional characterisation of an essential oil from a North African plant species, demonstrating activity in multiple cell-free and cell-based assays. The work identifies a lead compound composition but provides no evidence of efficacy, safety, or mechanism in animal or human systems, and is presented as a foundation for future research rather than as a tested therapeutic.
In vitro screening and computational docking study. Cell lines (HepG2 hepatocellular carcinoma cells) and laboratory-cultured pathogenic organisms (HRSV-A, Gram-negative bacteria, Candida kefyr, Culex pipiens larvae); non-cancerous cells mentioned as spared but not specified.. Intervention: Essential oil of Convolvulus trabutianus (EoCt) obtained by hydrodistillation.
EoCt identified 65 compounds by GC–MS with β-Thujone at 13.98% as the major constituent Anti-proliferative activity against HepG2 cells: IC50 = 80 µg/mL Dose-dependent antiviral effects against HRSV-A showing approximately 75% inhibition
No toxicity, safety or biocompatibility data reported despite being mentioned as a foundation for future work
This screening study does not provide evidence sufficient to guide clinical practice or therapeutic development. It identifies a candidate natural extract warranting further investigation but requires safety assessment, animal efficacy studies, and mechanistic validation before any therapeutic claim can be evaluated.
In vitro screening of a natural product extract across multiple biological activities with molecular modelling, but no animal or clinical data, no controlled comparisons, and no toxicity testing reported.
As stated by the source record.
Quoted from the source exactly as published.
This screening study does not provide evidence sufficient to guide clinical practice or therapeutic development. It identifies a candidate natural extract warranting further investigation but requires safety assessment, animal efficacy studies, and mechanistic validation before any therapeutic claim can be evaluated.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
ABSTRACT Essential oils (EOs) derived from medicinal plants represent a rich reservoir of bioactive natural products with therapeutic value across infectious diseases, cancer, and vector‐borne illnesses. Convolvulus trabutianus ( C. tarbutianus ) is an endemic North‐African species whose pharmacological potential has remained largely unexplored. The essential oil of C. trabutianus (EoCt) was obtained by hydrodistillation and characterized by GC–MS, identifying 65 compounds with β‐Thujone (13.98%) as the major constituent. EoCt showed anti‐proliferative activity against HepG2 cells (IC 50 = 80 µg/mL) while sparing noncancerous cells, dose‐dependent antiviral effects against HRSV‐A (∼75% inhibition), antibacterial activity against Gram‐negative bacteria, anticandidal activity against C. kefyr, and strong larvicidal activity against Culex pipiens. Molecular docking analysis revealed that thymol and carvacrol exhibited the greatest binding affinities for the target proteins, reinforced by favorable ADME/T profiles that supported their suitability as drug‐like candidates. Structure–activity relationship (SAR) analysis correlated the chemical composition of EoCt with its observed bioactivities, indicating a synergistic contribution of multiple terpenoid constituents to its broad‐spectrum effects. Overall, the present findings highlight EoCt as a promising natural source of bioactive compounds with concurrent anticancer, antiviral, antimicrobial, and larvicidal potential, and provided a foundation for subsequent research on its in vitro and in vivo efficacy, biocompatibility and safety in different biological systems.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.